StonvexLoading…
StonvexStonvexStonvexCore line items from CDRE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $610.31M | $567.56M | $482.53M | $457.84M |
Operating Income | $67.35M | $66.76M | $56.52M | $16.72M |
Net Income | $44.14M | $36.13M | $38.64M | $5.82M |
EPS (Diluted) | $1.02 | $0.90 | $1.02 | $0.16 |
Total Assets | $770.03M | $652.71M | $431.18M | $391.95M |
Total Liabilities | $452.23M | $341.20M | $234.02M | $226.06M |
Cash & Equivalents | $122.90M | $124.93M | $87.69M | $45.29M |
Free Cash Flow OCF − CapEx | $56.85M | $26.11M | $66.48M | $41.91M |
Shares Outstanding | 42.16M | 40.61M | 37.59M | 37.33M |